Molecular Testing During Aml Treatment For Early Prediction Of Clinical Response.

JOURNAL OF CLINICAL ONCOLOGY(2018)

引用 0|浏览7
暂无评分
摘要
7047Background: Early prediction of response in acute myeloid leukemia (AML) patients undergoing cytotoxic chemotherapy may have clinical utility. Currently, measurable residual disease (MRD) testi...
更多
查看译文
关键词
aml treatment,molecular testing,clinical response
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要